New Ray Medicine International Holding (HKSE:06108) EV-to-Revenue : 0.08 (As of May. 29, 2025)

New Ray Medicine International Holding EV-to-Revenue Chart

New Ray Medicine International Holding Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-Revenue		Get a 7-Day Free Trial					4.86	1.71	0.06	-0.40	0.15

New Ray Medicine International Holding Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial															0.06	-	-0.40	-	0.15

Competitive Comparison of New Ray Medicine International Holding's EV-to-Revenue

For the Pharmaceutical Retailers subindustry, New Ray Medicine International Holding's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

New Ray Medicine International Holding's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, New Ray Medicine International Holding's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where New Ray Medicine International Holding's EV-to-Revenue falls into.

New Ray Medicine International Holding EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

New Ray Medicine International Holding's EV-to-Revenue for today is calculated as:

New Ray Medicine International Holding's current Enterprise Value is HK$7.84 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. New Ray Medicine International Holding's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was HK$93.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Ray Medicine International Holding  (HKSE:06108) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

New Ray Medicine International Holding's PS Ratiofor today is calculated as:

New Ray Medicine International Holding's share price for today is HK$0.041.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Ray Medicine International Holding EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of New Ray Medicine International Holding's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

New Ray Medicine International Holding Business Description